These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 16573361)
1. Lessons on ethical decision making from the bioscience industry. Mackie JE; Taylor AD; Finegold DL; Daar AS; Singer PA PLoS Med; 2006 May; 3(5):e129. PubMed ID: 16573361 [TBL] [Abstract][Full Text] [Related]
2. What is the bioscience industry doing to address the ethical issues it faces? Novas C PLoS Med; 2006 May; 3(5):e142. PubMed ID: 16573362 [TBL] [Abstract][Full Text] [Related]
3. Can academic departments maintain industry relationships while promoting physician professionalism? Dubovsky SL; Kaye DL; Pristach CA; DelRegno P; Pessar L; Stiles K Acad Med; 2010 Jan; 85(1):68-73. PubMed ID: 20042827 [TBL] [Abstract][Full Text] [Related]
5. Financial relationships between research and pharmaceutical/biotech companies: disclosure is imperative. Caughey AB; Urato AC Am J Obstet Gynecol; 2007 Jan; 196(1):e13; author reply e13-4; discussion e14. PubMed ID: 16959207 [No Abstract] [Full Text] [Related]
6. A matter of interest. Nature; 2004 Aug; 430(7003):951. PubMed ID: 15329679 [No Abstract] [Full Text] [Related]
7. Ethics and industry-sponsored research. Pater JL; Parulekar W; O'Callagham C; Shepherd L; Eisenhouer E; Seymour L; Tu D; Ding K CMAJ; 2002 Mar; 166(5):581-2. PubMed ID: 11898934 [No Abstract] [Full Text] [Related]
8. Unethical business practices in U.S. health care alarm physician leaders. Weber DO Physician Exec; 2005; 31(2):6-13. PubMed ID: 15844791 [TBL] [Abstract][Full Text] [Related]
9. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine. Finkel AG Headache; 2006; 46(7):1181-5. PubMed ID: 16866722 [No Abstract] [Full Text] [Related]
11. Reaching a right and good decision: ethical decision-making and the frontline worker. Haddad AM Generations; 1994; 18(3):75-7. PubMed ID: 11660098 [No Abstract] [Full Text] [Related]
12. Gifts to physicians from the pharmaceutical industry: an ethical analysis. Marco CA; Moskop JC; Solomon RC; Geiderman JM; Larkin GL Ann Emerg Med; 2006 Nov; 48(5):513-21. PubMed ID: 17052550 [TBL] [Abstract][Full Text] [Related]
13. Conflicts of interest: disclosure and resolution. van Hall SF Cost Qual Q J; 1998 Mar; 4(1):21-5. PubMed ID: 10178952 [No Abstract] [Full Text] [Related]
14. Practicing preventive ethics-the keys to avoiding ethical conflicts in health care. McCullough LB Physician Exec; 2005; 31(2):18-21. PubMed ID: 15844794 [No Abstract] [Full Text] [Related]
15. An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug development. Markman M Cancer; 2008 May; 112(9):1871-3. PubMed ID: 18318430 [No Abstract] [Full Text] [Related]
16. Tough talker quits Congress for bioindustry. Wadman M Nature; 2004 Jul; 430(6999):495. PubMed ID: 15282573 [No Abstract] [Full Text] [Related]
17. Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest? Alpert JS Am J Med; 2008 Apr; 121(4):253-5. PubMed ID: 18374678 [No Abstract] [Full Text] [Related]
18. Corporate strategies for managing bioethical issues. Arakelian C Drug Discov Today; 2003 May; 8(9):386-8. PubMed ID: 12706652 [No Abstract] [Full Text] [Related]